<DOC>
	<DOCNO>NCT00050791</DOCNO>
	<brief_summary>This double blind placebo control clinical study design determine effect leptin change occur body weight loss achieve low calorie diet .</brief_summary>
	<brief_title>Effects Leptin Treatment Weight Loss</brief_title>
	<detailed_description>Leptin hormone produce fat tissue act brain . Leptin play key role regulate energy balance body weight animal human . When person lose weight , leptin concentration blood reduce . Reduction blood leptin level find relate decreased metabolic rate ( rate body burn calorie ) , increase appetite , many physiological hormonal change may lead failure diet . This study aim test maintain leptin pre-diet level range ameliorate change occur body weight loss . If change reduce , process weight loss could easier faster adhere low calorie diet . In study , leptin placebo administer injection skin , way similar injection insulin diabetic patient . 50 % subject participate study treat leptin 50 % treated placebo . Blood leptin level maintain pre-diet range leptin treat subject leptin treatment . Subjects treat placebo also lose weight adhere liquid diet provide Rockefeller University Bio-nutrition Department . The investigator participants n't know leptin placebo use since double blind study . To participate study , subject stay Rockefeller University Hospital inpatient two month continue study outpatient 4 month . During outpatient period , subject attend clinic visit week . During first 3 week study , subject introduce weight stabilization liquid diet . During time , initial weight maintain baseline study test perform . When test complete , low calorie liquid diet leptin placebo administration initiate . Weight monitor 10 % weight loss achieve . At time , second test period perform inpatient setting . When test complete , weight loss leptin placebo treatment continue home outpatient set 20 % weight loss achieve . When period complete , third test period perform inpatient setting . The last month study dedicate transition liquid diet solid food , weight maintenance education provide hospital staff outpatient setting . A solid food weight maintenance diet provide participant period . At end period , two day test perform leptin/placebo administration discontinue . Study test period perform 12 day inpatient set include variety blood draw , urine collection , metabolic behavioral test know affected weight loss .</detailed_description>
	<criteria>( 1 ) adult female , age 2545 BMI 2945 , acute chronic illness . Pregnant woman permit participate study . 1 . Chronic illness mild form illness related obesity ( hypertension , hyperlipidemia etc ) require medical treatment 2 . Diabetes Mellitus 3 . Chronic drug treatment medical condition 4 . Inability give inform consent 5 . Inability give contact information ( outpatient follow ) include permanent residence , provide evidence stable living environment study period . 6 . Active weight reduction 7 pound last 3 month 7 . Weight screen 6 % low maximal life time weight . 8 . History bleed blood clot disorder . 9 . Changes smoke habit last 3 month . 10 . Pregnancy breast feeding woman . 11 . Allergic reaction local anesthetic 12 . History anaphylaxis anaphylactoidlike reaction 13 . Tendency form scar ( keloid ) easily 14 . Subjects know hypersensitivity E Coliderived proteins component A100 preparation . 15 . Irregular menses 16 . HIV hepatitis B C positive subject .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Weightloss</keyword>
	<keyword>Leptin</keyword>
	<keyword>Diet</keyword>
	<keyword>Reducing</keyword>
	<keyword>Overweight</keyword>
	<keyword>Fat</keyword>
</DOC>